[HTML][HTML] Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic
…, O Topolcan, R Kucera, S Kormunda - American Journal of …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccination may
fail to sufficiently protect transplant recipients against coronavirus disease 2019 (COVID-19). …
fail to sufficiently protect transplant recipients against coronavirus disease 2019 (COVID-19). …
Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed …
…, P Jindra, O Hes, M Bouda, S Kormunda… - …, 2009 - journals.lww.com
Background. Cytomegalovirus (CMV) is a risk factor for acute renal allograft rejection. The
aim of this study was to determine the impact of CMV viremia on subclinical rejection (SCR) …
aim of this study was to determine the impact of CMV viremia on subclinical rejection (SCR) …
The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection
T Reischig, P Jindra, M Švecová, S Kormunda… - Journal of clinical …, 2006 - Elsevier
BACKGROUND: Cytomegalovirus (CMV) disease is a risk factor for allograft rejection in
renal transplant (RTx) recipients. However, the role of asymptomatic CMV infection remains …
renal transplant (RTx) recipients. However, the role of asymptomatic CMV infection remains …
[HTML][HTML] Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy
…, P Jindra, K Pivovarcikova, S Kormunda… - American Journal of …, 2019 - Elsevier
Polyomavirus BK (BKV) is the cause of polyomavirus-associated nephropathy resulting in
premature graft loss. There are limited data regarding the role of cytomegalovirus (CMV) …
premature graft loss. There are limited data regarding the role of cytomegalovirus (CMV) …
A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer
…, S Filip, R Kozevnikova, S Kormunda - Anticancer …, 2009 - ar.iiarjournals.org
Background: Optimal chemotherapy (CT) for advanced breast treatment should be effective,
well tolerated and convenient. In this study the efficacy and safety of the fully oral …
well tolerated and convenient. In this study the efficacy and safety of the fully oral …
[HTML][HTML] Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized …
…, H Hermanova, O Hes, D Lysak, S Kormunda… - BMC infectious …, 2018 - Springer
Background Cytomegalovirus (CMV) prophylaxis may prevent CMV indirect effects in renal
transplant recipients. This study aimed to compare the efficacy of valganciclovir and …
transplant recipients. This study aimed to compare the efficacy of valganciclovir and …
Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients
J Fidlerova, P Kleiblova, M Bilek, S Kormunda… - Cancer chemotherapy …, 2010 - Springer
Purpose Decreased 5-fluorouracil catabolism has been considered a major factor
contributing to fluoropyrimidine (FP)-related toxicity. Alterations in the dihydropyrimidine …
contributing to fluoropyrimidine (FP)-related toxicity. Alterations in the dihydropyrimidine …
[HTML][HTML] Risk of postoperative bleeding in tonsillectomy for peritonsillar abscess, as opposed to in recurrent and chronic tonsillitis—a retrospective study
…, J Hanáková, P Hrabačka, S Kormunda… - International Journal of …, 2021 - mdpi.com
Tonsillectomy is a routine surgery in otorhinolaryngology and the occurrence of postoperative
bleeding is not a rare complication. The aim of this retrospective, observational, analytic, …
bleeding is not a rare complication. The aim of this retrospective, observational, analytic, …
Contribution of the β-ureidopropionase (UPB1) gene alterations to the development of fluoropyrimidine-related toxicity
J Fidlerova, P Kleiblova, S Kormunda, J Novotny… - Pharmacological …, 2012 - Elsevier
Background An impairment of the 5-fluorouracil (5-FU) catabolic pathway, represented by
alterations in the dihydropyrimidine dehydrogenase (DPYD) gene, is considered a crucial …
alterations in the dihydropyrimidine dehydrogenase (DPYD) gene, is considered a crucial …
Changes of serum thymidine kinase in children with acute leukemia
…, Z Cerna, L Sasek, J Finek, S Kormunda - Anticancer …, 2007 - ar.iiarjournals.org
Background: Thymidine kinase (TK) is involved in nucleic acid synthesis and is therefore
considered to be an important proliferation tumor marker. Our main goal was to determine the …
considered to be an important proliferation tumor marker. Our main goal was to determine the …